AP
Amylyx Pharmaceuticals, Inc.
OrganizationHeard in 5 episodes across 1 show since Aug 2026
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative and metabolic disorders.
Episodes
5
across 1 show
First heard
Aug 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
5
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 5 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
Episodes
5 episodes featuring Amylyx Pharmaceuticals, Inc., newest first
- Aug 18, 2026
Klarna cuts outlook as Amylyx rallies on trial resultsStock MoversAug 18, 2026 - Aug 18, 2026
Amer Sports gains while Klarna stumbles after IPOStock MoversAug 18, 2026 - Aug 18, 2026
Drug-trial optimism meets market-wide cautionStock MoversAug 18, 2026 - Aug 18, 2026
Amylyx surges on trial success while Klarna plunges on weak guidanceStock MoversAug 18, 2026 - Aug 18, 2026
Amer Sports and Amylyx surge as Klarna plunges on missed expectationsStock MoversAug 18, 2026